12/16/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
6:15 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
4:44 PM | Foghorn Therapeutics (Subject)
Klarman Family Foundation (Filed by)
| Form SC 13G/A | |
09/24/2024
3:01 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:00 PM | Flynn James E (Filed by)
Foghorn Therapeutics (Subject)
| Form SC 13G | |
09/18/2024
3:01 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:40 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/11/2024
3:00 PM | Bellon Steven F. (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:31 PM | Bellon Steven F. (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
7:44 AM | Foghorn Therapeutics (Filer)
| Form 424B5 | |
08/08/2024
6:02 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2024
3:04 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:48 AM | FMR LLC (Filed by)
Foghorn Therapeutics (Subject)
| Form SC 13G/A | |
05/23/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:31 PM | Foghorn Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
7:02 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
3:54 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/06/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
7:00 AM | Foghorn Therapeutics (Filer)
| Form DEF 14A | |
05/03/2024
7:01 AM | Foghorn Therapeutics (Filer)
| Form DEFA14A | |
05/03/2024
7:03 AM | Foghorn Therapeutics (Filer)
| Form ARS | |
04/16/2024
6:01 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:41 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
3:19 PM | Cavalie Fanny (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:09 AM | Foghorn Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
6:11 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
